Knoll Capital Management as of March 31, 2018
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 13 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abeona Therapeutics | 34.8 | $34M | 2.4M | 14.35 | |
| Corbus Pharmaceuticals Hldgs | 24.2 | $24M | 3.9M | 6.10 | |
| Biohaven Pharmaceutical Holding | 19.8 | $19M | 750k | 25.76 | |
| Ampio Pharmaceuticals | 9.1 | $8.8M | 2.6M | 3.40 | |
| Krystal Biotech (KRYS) | 3.1 | $3.0M | 300k | 10.09 | |
| Vascular Biogenics | 2.1 | $2.1M | 897k | 2.30 | |
| Anavex Life Sciences (AVXL) | 2.0 | $2.0M | 724k | 2.76 | |
| Soligenix | 1.7 | $1.6M | 838k | 1.96 | |
| Aldeyra Therapeutics (ALDX) | 1.0 | $931k | 124k | 7.50 | |
| Volitionrx (VNRX) | 0.9 | $844k | 352k | 2.40 | |
| Eiger Biopharmaceuticals | 0.8 | $741k | 75k | 9.85 | |
| Evoke Pharma | 0.6 | $572k | 275k | 2.08 | |
| Advaxis | 0.1 | $45k | 113k | 0.40 |
